Middle East Respiratory Syndrome (MERS) and Novel Coronavirus Disease-2019 (COVID-19): From causes to preventions in Saudi Arabia

Mohammad H. Alyami, Hamad S. Alyami, Ansaar Warraich

Research output: Contribution to journalReview articlepeer-review

Abstract

Saudi Arabia is one of the countries that has been affected by COVID-19. At the beginning of March 2020, it revealed a steadily rising number of laboratory-confirmed cases. By 20th May 2020, 59,854 infected cases had been confirmed, with 329 deaths. To prevent a further outbreak of COVID-19, this article discusses the current understanding of COVID-19 and compares it with the outbreak of Middle East Respiratory Syndrome (MERS) in 2012 in Saudi Arabia. It also discusses the causes, transmission, symptoms, diagnosis, treatments and prevention measures to identify an applicable measure to control COVID-19.
Original languageEnglish
Pages (from-to)1481-1491
Number of pages11
JournalSaudi Pharmaceutical Journal
Volume28
Issue number11
Early online date24 Sep 2020
DOIs
Publication statusPublished - Nov 2020

Bibliographical note

Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)

Keywords

  • Causes
  • Coronavirus disease-2019 (COVID-19)
  • Diagnosis
  • Middle East Respiratory Syndrome (MERS)
  • Prevention measures
  • Saudi Arabia
  • Symptoms
  • Transmission
  • Treatments

Fingerprint Dive into the research topics of 'Middle East Respiratory Syndrome (MERS) and Novel Coronavirus Disease-2019 (COVID-19): From causes to preventions in Saudi Arabia'. Together they form a unique fingerprint.

Cite this